<DOC>
	<DOCNO>NCT02714569</DOCNO>
	<brief_summary>The purpose two-part study evaluate safety tolerability study drug know LY3202328 healthy overweight participant Part A , dyslipidemia ( abnormal blood fat ) Part B .</brief_summary>
	<brief_title>A Study Evaluate LY3202328 Overweight Healthy Participants Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Be healthy , determined medical history physical examination Male participant must agree use reliable method birth control study 3 month follow last dose investigational product Female participant must 40 70 year old , either postmenopausal hysterectomy , pregnant lactating Be stable diet exercise regimen great ( &gt; ) 3 month prior Have body mass index ( BMI ) 25.0 ( Part A ) 27.0 ( Part B ) 40.0 kilogram per meter square Have fast triglyceride ( TG ) 150 499 milligram per deciliter ( mg/dL ) ( Part B ) Have fast lowdensity lipoprotein cholesterol ( LDLc ) 100 200 mg/dL ( Part B ) Have estimate glomerular filtration rate great equal ( ≥ ) 60 milliliter per minute/1.73 meter square proteinuria Be normotensive define supine systolic blood pressure ( BP ) less equal ( ≤ ) 150 millimeter mercury ( mm Hg ) diastolic BP ≤ 100 mm Hg , without use antihypertensive Are take statin , proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) medication , start take TG lower agent ( example , niacin , fish oil ) Are currently enrol clinical trial involve investigational product offlabel use drug device , concurrently enrol type medical research , participate clinical trial involve investigational product nonapproved use drug within last 30 day within 5 halflives Have abnormal electrocardiogram correct QT antihypertensive treatment Have current prior history significant cardiovascular disease Show evidence hepatitis C virus ( HCV ) , Hepatitis B chronic liver disease Have alcohol intake exceed 7 unit per week 3 unit per day , unwilling stop alcohol consumption duration study ( 1 unit = 12 ounce 360 mL beer ; 5 ounce 150 mL wine ; 1.5 ounce 45 mL distilled spirit ) , regular user know drug abuse Have history untreated endocrine illness diabetes mellitus Have medication supplement weight loss within 3 month Have history active neuropsychiatric disease pharmacological therapy condition ( Part B , ) Show evidence human immunodeficiency virus ( HIV ) infection Have medication know inhibit cytochrome P450 , family 3 , subfamily A ( CYP3A ) Pglycoprotein ( Pgp ) , regularly consume grapefruit Have donate blood 500 mL within last month Smoke &gt; 10 cigarette per day unwilling follow smoking rule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>